#ESCCongress – Meta-analysis of randomized trials | SGLT-2 inhibitors in patients with heart failure.

SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials – The Lancet (free registration required)

Commentary on Twitter

Our meta-analysis of SGLT2 inhibitors in HF is now online in @TheLancet showing a
consistent reduction in the risk of CV death and HF hospitalisation in a broad range of 21,947
patients across range of EF and in different care settingshttps://t.co/qnxgayR235 pic.twitter.com/x0RsINoE9y

— Kieran Docherty (@Kieranfdocherty) August 27, 2022